Osteoporosis Experts Discuss Bisphosphonates, Chronic Kidney Disease

CHICAGO—The osteoporosis session at the 2018 ACR/ARHP Annual Meeting opened with a discussion by Kenneth Saag, MD, MSc, professor of medicine at the University of Alabama, Birmingham, in which he highlighted adverse events associated with osteoporosis medications. Dr. Saag began his presentation by emphasizing that, above all, the audience should keep in mind that the... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Conditions Meeting Reports 2018 ACR/ARHP Annual Meeting Association of Rheumatology Professionals (ARP) Bisphosphonate chronic kidney disease Source Type: research